OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer related safety with SGLT2-i and GLP1-RAs: Should we worry?
Marco Gallo, Matteo Monami, Alberto Ragni, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110624-110624
Closed Access | Times Cited: 6
Marco Gallo, Matteo Monami, Alberto Ragni, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110624-110624
Closed Access | Times Cited: 6
Showing 6 citing articles:
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors
Mohamed S. Dabour, Mina Y. George, Mary R. Daniel, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 159-182
Open Access | Times Cited: 15
Mohamed S. Dabour, Mina Y. George, Mary R. Daniel, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 159-182
Open Access | Times Cited: 15
Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials
Giovanni Antonio Silverii, Matteo Monami, Marco Gallo, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 3, pp. 891-900
Open Access | Times Cited: 32
Giovanni Antonio Silverii, Matteo Monami, Marco Gallo, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 3, pp. 891-900
Open Access | Times Cited: 32
Insights into the impact of sodium‐glucose cotransporter 2 inhibition on urinary tract malignancy: A two‐sample Mendelian randomization
Zeyu Han, Yazhou He, Xue Li, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1986-1989
Closed Access | Times Cited: 5
Zeyu Han, Yazhou He, Xue Li, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1986-1989
Closed Access | Times Cited: 5
Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
Djordje S. Popovic, Dimitrios Patoulias, Lazar Popović, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111758-111758
Closed Access | Times Cited: 4
Djordje S. Popovic, Dimitrios Patoulias, Lazar Popović, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111758-111758
Closed Access | Times Cited: 4
Deciphering the Causal Relationship between Sodium-glucose Cotransporter 2 Inhibition and Cancer Risks: A Comprehensive Mendelian Randomization Study
Liyin Zhang, Baorui Xue, Fangyang Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 3903-3912
Open Access | Times Cited: 1
Liyin Zhang, Baorui Xue, Fangyang Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 3903-3912
Open Access | Times Cited: 1
Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies
Linda Piras, Michela Zuccanti, Giacomo Tini, et al.
Hearts (2024) Vol. 5, Iss. 4, pp. 529-546
Open Access
Linda Piras, Michela Zuccanti, Giacomo Tini, et al.
Hearts (2024) Vol. 5, Iss. 4, pp. 529-546
Open Access
